Elevance Health Inc. Common Stock vs Xpeng Inc - ADR — how do they compare? Elevance Health Inc. Common Stock trades at $412.7 (market cap $86.95B), while Xpeng Inc - ADR trades at $9.9 (market cap $9.16B). The key difference: Elevance Health Inc. Common Stock is far larger — about 9.5× Xpeng Inc - ADR's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| ELV | XPEV | |
|---|---|---|
Market Cap | $86.95B | $9.16B |
Volume | 782,706 | 5,030,325 |
Sector | Health | Consumer Cyclical |
52-Week High | $426.79 | $28.07 |
52-Week Low | $280.74 | $9.25 |
Enterprise Value | $107.76B | $11.09B |
Dividend Yield | 1.72% | — |
Typical Hold Time | — | 80 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XPeng (XPEV) trades at $9.55, down 0.31% with a bearish technical signal. The company shows strong revenue growth to $76.72B in 2025 but remains unprofitable with a net margin of -4.14%. Recent vehicle deliveries of 41,256 in September 2026 and the upcoming G9L SUV launch at the Paris Motor Show highlight expansion efforts. Analyst consensus is bullish with a $17.55 price target, though earnings misses in Q1 and Q2 2026 raise execution concerns.
The stock presents a high-risk, high-reward opportunity. Significant revenue growth and analyst optimism are offset by persistent losses and competitive pressures. Key catalysts include successful global expansion and profitability improvements, while risks involve execution missteps and macroeconomic headwinds in the EV sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →